Norges Bank’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-375,713
Closed -$4.25M – 2107
2022
Q2
$4.25M Buy
375,713
+106,383
+39% +$1.28M ﹤0.01% 1803
2022
Q1
$4.37M Buy
269,330
+186,133
+224% +$4.77M ﹤0.01% 1894
2021
Q4
$3.94M Sell
83,197
-160,697
-66% -$9.6M ﹤0.01% 1950
2021
Q3
$17.7M Buy
243,894
+213,894
+713% +$15.5M ﹤0.01% 1556
2021
Q2
$2.52M Hold
30,000
– – ﹤0.01% 1991
2021
Q1
$1.45M Hold
30,000
– – ﹤0.01% 2018
2020
Q4
$1.42M Hold
30,000
– – ﹤0.01% 1991
2020
Q3
$1.41M Hold
30,000
– – ﹤0.01% 1999
2020
Q2
$899K Hold
30,000
– – ﹤0.01% 2017
2020
Q1
$390K Buy
+30,000
New +$375K ﹤0.01% 2018

Other funds holding NBP

Norges Bank's NBP Position: Q3 2022 in Review

Norges Bank sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 375,713 shares — an estimated $4.25M sold.

Norges Bank first reported a position in NBP in Q1 2020 and held it in 10 quarters. The position peaked at $17.7M in Q3 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • Norges Bank reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Norges Bank sold 375,713 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $4.25M.
  • Norges Bank first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and held it in 10 quarters.
  • Norges Bank's NovaBridge Biosciences American Depositary Shares position peaked at $17.7M in Q3 2021.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.